| 000 | 01426 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512195014.0 | ||
| 264 | 0 | _c19800926 | |
| 008 | 198009s 0 0 eng d | ||
| 022 | _a0174-4879 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTörök, E | |
| 245 | 0 | 0 |
_aClinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum). _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology, therapy, and toxicology _c1980 |
||
| 300 |
_a200-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Output _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhysical Exertion |
| 650 | 0 | 4 |
_aPropanolamines _xtherapeutic use |
| 650 | 0 | 4 |
_aPropranolol _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aIstvánffy, M | |
| 700 | 1 | _aHalmágyi, M | |
| 700 | 1 | _aWagner, M | |
| 700 | 1 | _aCsukás, M | |
| 773 | 0 |
_tInternational journal of clinical pharmacology, therapy, and toxicology _gvol. 18 _gno. 5 _gp. 200-7 |
|
| 999 |
_c6104726 _d6104726 |
||